Qube Research & Technologies (QRT)
BFRI icon

Qube Research & Technologies (QRT)’s Biofrontera BFRI Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio BFRI Stock Details BFRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-685
Closed -$103K – 2454
2021
Q4 		$103K Buy
+685
New +$75K ﹤0.01% 2134

Other funds holding BFRI

BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Qube Research & Technologies (QRT)'s BFRI Position: Q1 2022 in Review

Qube Research & Technologies (QRT) sold out of Biofrontera (BFRI) in Q1 2022, closing a stake of 685 shares — an estimated $103K sold.

Qube Research & Technologies (QRT) first reported a position in BFRI in Q4 2021 and held it in 1 quarter. The position peaked at $103K in Q4 2021. 12 funds tracked by Wall St. Rank hold BFRI as of Q1 2022.

  • Qube Research & Technologies (QRT) reported no remaining Biofrontera position as of Q1 2022 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 685 Biofrontera shares in Q1 2022, an estimated $103K.
  • Qube Research & Technologies (QRT) first reported a position in Biofrontera in Q4 2021 and held it in 1 quarter.
  • Qube Research & Technologies (QRT)'s Biofrontera position peaked at $103K in Q4 2021.
  • 12 funds tracked by Wall St. Rank held Biofrontera as of Q1 2022.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2022, filed 9 May 2022.